Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11421265 Optimization of multigene analysis of tumor samples

Patent 11421265 was granted and assigned to Foundation Medicine on August, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Foundation Medicine

Current Assignee

Foundation Medicine

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

114212650

Patent Inventor Names

Alexander Nevin Parker0

Doron Lipson0

Geoffrey Alan Otto0

Mikhail G. Shapiro0

Mima Jarosz0

Philip James Stephens0

Roman Yelensky0

Sean R. Downing0

Date of Patent

August 23, 2022

Patent Application Number

162453010

Date Filed

January 11, 2019

Patent Citations

‌

US Patent 10041127 Systems and methods to detect rare mutations and copy number variation

‌

US Patent 11118213 Optimization of multigene analysis of tumor samples

Patent Citations Received

‌

US Patent 11959141 Multigene analysis of tumor samples

Patent Primary Examiner

‌

Katherine D Salmon

A method of analyzing a tumor sample comprising:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11421265 Optimization of multigene analysis of tumor samples

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API